Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics' Focus::Lymphoma Panel

Cancer Genetics has launched Focus::Lymphoma, a CLIA-validated, next-generation sequencing panel to detect and monitor the most common mature B-cell lymphomas. The panel enables the targeted sequencing of 220 genes and has the ability to customize the reporting that provides clinically actionable information to determine patients' treatment options. The product can detect mutations in genes such as BTK and PLCG2, which have been recently attributed to therapy resistance, and offers information on genes such as MT2D, which is frequently mutated in B-cell lymphomas, but is not currently available through other commercial platforms.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.